Sofia A Medeiros Selected Research

Pharmaceutical Preparations

1/2020

Multimodal mechanisms and enhanced efficiency of atrial fibrillation cardioversion by pulmonary delivery of a novel flecainide formulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sofia A Medeiros Research Topics

Disease

2	Coronary Stenosis (Coronary Artery Stenosis) 10/2021 - 01/2020
2	Atrial Fibrillation 01/2020 - 01/2020
1	Myocardial Infarction 01/2021
1	Acute Coronary Syndrome 01/2021
1	Bundle-Branch Block (Fascicular Block) 11/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Pathologic Constriction (Stenosis) 01/2020

Drug/Important Bio-Agent (IBA)

1	regadenoson FDA Link 10/2021
1	TroponinIBA 01/2021
1	Flecainide (Tambocor)FDA LinkGeneric 01/2020
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Vasodilator Agents (Vasodilators)IBA 01/2020
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2020

Therapy/Procedure

1	Cardiac Resynchronization Therapy 11/2020
1	Electric Countershock (Cardioversion) 01/2020